Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy

To evaluate the timing and distribution of first renal cell carcinoma metastasis after nephrectomy stratified by nodal status.

[1]  Jeff Scott.  Renal Cell , 2020, Definitions.

[2]  M. Scorsetti,et al.  Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma , 2019, The Journal of urology.

[3]  J. Cheville,et al.  The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. , 2018, European urology.

[4]  U. Capitanio,et al.  The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta‐analysis , 2018, BJU international.

[5]  J. Cheville,et al.  Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi‐Institutional Analysis , 2017, The Journal of urology.

[6]  K. Ahrar,et al.  Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control , 2017, The Journal of bone and joint surgery. American volume.

[7]  Jeffrey A. Cadeddu,et al.  Adult Urology Oncology : Adrenal / Renal / Upper Tract / Bladder lized Renal Cancer : AUA Guideline , 2017 .

[8]  M. Atkins,et al.  Immune checkpoint inhibitors in advanced renal cell carcinoma: experience to date and future directions. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Chad A. LaGrange,et al.  Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[10]  C. Drake,et al.  Immune checkpoint blockade: a common denominator approach to cancer therapy. , 2015, Cancer cell.

[11]  C. Wood,et al.  The role of lymph node dissection in renal cell carcinoma. , 2011, The Urologic clinics of North America.

[12]  C. Wood,et al.  The role of lymph node dissection in renal cell carcinoma , 2011, International Journal of Clinical Oncology.

[13]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[14]  M. Sotomayor,et al.  Impact of Lymph Node Invasion and Sarcomatoid Differentiation on the Survival of Patients with Locally Advanced Renal Cell Carcinoma , 2010, Urologia Internationalis.

[15]  M. Cooperberg,et al.  Renal cell cancer stage migration , 2008, Cancer.

[16]  S. Taneja,et al.  Lymph node dissection during the surgical treatment of renal cancer in the modern era. , 2008, International braz j urol : official journal of the Brazilian Society of Urology.

[17]  J. Cheville,et al.  A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. , 2005, The Journal of urology.

[18]  J. Cheville,et al.  The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus , 2004, BJU international.

[19]  J. Cheville,et al.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.

[20]  J. Cheville,et al.  The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. , 2002, The Journal of urology.

[21]  E. Seaman,et al.  Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma. , 1996, Urology.

[22]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[23]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.